Ever since GSK in December 2006 broke a then industry record by licensing a drug for leukaemia from Genmab for 1.6bn, taking a 10 per cent stake in the process, the pharmaceutical world has expected GSK to one day launch a full-scale cash offer.
Theravance and Elan announced in a press release that Elan will purchase a participation interest in potential future royalty payments related to four respiratory programs partnered with GlaxoSmithKline : RELVAR ELLIPTA/BREO ELLIPTA , ANORO ELLIPTA , MABA monotherapy , and vilanterol monotherapy.
OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel therapeutics that target cancer stem cells , or tumor-initiating cells, today announced clinical progress with its Anti-Notch2/3 product candidate, which will trigger an $8 million milestone payment from the company's strategic collaborator GlaxoSmithKline .
's stock had its "buy" rating reiterated by equities research analysts at TheStreet in a research note issued to investors on Tuesday, AnalystRatingsNetwork reports.
Beyond creating jobs, corporations doing business in North Carolina can shave their tax bills in various ways, and a rundown of the state's largest tax credit takers in 2012 shows just that.
In order to support its sale of antibiotics in medical and trade channels in Hong Kong, Pharma Giant GlaxoSmithKline has selected market expansion company DKSH to provide contract sales services in both private clinics and trade channel.
Brian is a member of The Motley Fool Blog Network -- entries represent the personal opinion of the blogger and are not formally edited.
For 1QCY2013 GlaxoSmithkline Consumer Healthcare posted a 18.5% yoy growth in net profit to Rs.156cr, aided by a 15.6% yoy growth in topline and a 50% yoy increase in auxiliary income.
U.S. stocks closed little changed on Monday, pausing after hitting record highs last week, but strength in health care issues helped to keep declines in check.
's stock had its "buy" rating reiterated by investment analysts at Citigroup in a note issued to investors on Monday, ARN reports.
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! LONDON, UK, 13 May, 2013 - Skyepharma PLC , the expert oral and inhalation drug delivery company, announces that the United States Food and Drug Administration has approved the New Drug Application for BREOa ELLIPTAa , a combination product submitted by ... (more)
U.K. stocks managed to eke out an eighth straight day of gains on Monday, as Royal Dutch Shell PLC rose after announcing a share buyback and GlaxoSmithKline PLC climbed after a new drug approval.
Elan Corp. Monday said it had reached a $1 billion deal with Theravance Inc. for a share in the royalty stream of four respiratory drug programs, as the Irish company fends off approaches from pharmaceutical investor Royalty Pharma.